Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $352,312 (100.0% shares, 0.0% debt)

Holdings (15)

— ARIAD PHARMACEUTICALS INC 27.0%

Value ($000) $94,961 Shares 12,850,000 Est. Cost $6.73 Unrealized —

BIIB BIOGEN INC 21.3%

Value ($000) $74,964 Shares 310,000 Est. Cost $287.35 Unrealized -8.3%

— MEDICINES CO 16.7%

Value ($000) $58,919 Shares 1,752,000 Est. Cost $29.63 Unrealized —

— INTRA CELLULAR THERAPIES INC 7.4%

Value ($000) $26,203 Shares 675,000 Est. Cost $27.96 Unrealized —

PCRX PACIRA PHARMACEUTICALS INC 6.3%

Value ($000) $22,025 Shares 653,000 Est. Cost $57.93 Unrealized -15.2%

— RAPTOR PHARMACEUTICAL CORP 4.4%

Value ($000) $15,438 Shares 2,875,000 Est. Cost $4.64 Unrealized —

— ARRAY BIOPHARMA INC 4.3%

Value ($000) $15,308 Shares 4,300,000 Est. Cost $3.36 Unrealized —

DGX QUEST DIAGNOSTICS INC 3.7%

Value ($000) $12,944 Shares 159,000 Est. Cost $46.05 Unrealized +36.8%

PRGO PERRIGO CO PLC 2.6%

Value ($000) $9,067 Shares 100,000 Est. Cost $103.58 Unrealized 0.0%

— APRICUS BIOSCIENCES INC 1.6%

Value ($000) $5,784 Shares 14,479,052 Est. Cost $1.10 Unrealized —

— ADVAXIS INC 1.4%

Value ($000) $4,853 Shares 600,000 Est. Cost $8.09 Unrealized —

— AEGERION PHARMACEUTICALS INC 1.1%

Value ($000) $3,947 Shares 2,649,000 Est. Cost $21.95 Unrealized —

ABBV ABBVIE INC. 0.9%

Value ($000) $3,095 Shares 50,000 Est. Cost $38.85 Unrealized +5.5%

— VIVUS INC 0.8%

Value ($000) $2,882 Shares 2,573,943 Est. Cost $9.08 Unrealized —

— AVEO PHARMACEUTICALS INC 0.5%

Value ($000) $1,922 Shares 2,000,000 Est. Cost $1.84 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$94,961	27.0%	$6.73	—	COM	04033A100
BIIB	BIOGEN INC	310,000	$74,964	21.3%	$287.35	-8.3%	COM	09062X103
—	MEDICINES CO	1,752,000	$58,919	16.7%	$29.63	—	COM	584688105
—	INTRA CELLULAR THERAPIES INC	675,000	$26,203	7.4%	$27.96	—	COM	46116X101
PCRX	PACIRA PHARMACEUTICALS INC	653,000	$22,025	6.3%	$57.93	-15.2%	COM	695127100
—	RAPTOR PHARMACEUTICAL CORP	2,875,000	$15,438	4.4%	$4.64	—	COM	75382F106
—	ARRAY BIOPHARMA INC	4,300,000	$15,308	4.3%	$3.36	—	COM	04269X105
DGX	QUEST DIAGNOSTICS INC	159,000	$12,944	3.7%	$46.05	+36.8%	COM	74834L100
PRGO	PERRIGO CO PLC	100,000	$9,067	2.6%	$103.58	0.0%	SHS	G97822103
—	APRICUS BIOSCIENCES INC	14,479,052	$5,784	1.6%	$1.10	—	COM	03832V109
—	ADVAXIS INC	600,000	$4,853	1.4%	$8.09	—	COM NEW	007624208
—	AEGERION PHARMACEUTICALS INC	2,649,000	$3,947	1.1%	$21.95	—	COM	00767E102
ABBV	ABBVIE INC.	50,000	$3,095	0.9%	$38.85	+5.5%	COM	00287Y109
—	VIVUS INC	2,573,943	$2,882	0.8%	$9.08	—	COM	928551100
—	AVEO PHARMACEUTICALS INC	2,000,000	$1,922	0.5%	$1.84	—	COM	053588109